Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy

In vivo tumor reprogrammed-antigen presenting cells induction elicited clonal expansion of cancer-specific T cells, established cancer-specific immune memory, and ultimately promoted leukemia eradication.